Published in J Cell Biochem on September 01, 2009
Wnt/beta-catenin signaling and small molecule inhibitors. Curr Pharm Des (2013) 1.44
The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology (2011) 1.04
Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells. Exp Mol Med (2011) 0.94
Biochemical and structural characterization of β-catenin interactions with nonphosphorylated and CK2-phosphorylated Lef-1. J Mol Biol (2010) 0.88
Dynamic expression of a LEF-EGFP Wnt reporter in mouse development and cancer. Genesis (2010) 0.88
CK2α is essential for embryonic morphogenesis. Mol Cell Biochem (2011) 0.85
The γ-Protocadherin-C3 isoform inhibits canonical Wnt signalling by binding to and stabilizing Axin1 at the membrane. Sci Rep (2016) 0.78
Xenopus paraxial protocadherin inhibits Wnt/β-catenin signalling via casein kinase 2β. EMBO Rep (2012) 0.78
Asymmetric Localization of CK2α During Xenopus Oogenesis. Hum Genet Embryol (2012) 0.76
Skin renewal activity of non-thermal plasma through the activation of β-catenin in keratinocytes. Sci Rep (2017) 0.75
Wnt signalling in stem cells and cancer. Nature (2005) 19.26
beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J (1997) 12.97
WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet (2004) 10.38
A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage. Cell (1982) 9.11
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J (1998) 7.59
Three-dimensional structure of the armadillo repeat region of beta-catenin. Cell (1997) 7.35
One-thousand-and-one substrates of protein kinase CK2? FASEB J (2003) 6.89
Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem (2006) 6.32
The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell (1997) 6.10
Regulation of cadherin adhesive activity. J Cell Biol (2000) 5.63
Wnt signaling in disease and in development. Cell Res (2005) 5.53
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J (2003) 5.11
Lack of beta-catenin affects mouse development at gastrulation. Development (1995) 4.95
The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol (2003) 4.89
Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem (2007) 4.60
Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol (2000) 4.36
The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell (2001) 4.32
Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell (1994) 4.24
E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol (2001) 4.04
Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol (2008) 3.87
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev (2002) 3.80
E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci (1999) 3.55
Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity. Dev Cell (2003) 2.95
The entire mesodermal mantle behaves as Spemann's organizer in dorsoanterior enhanced Xenopus laevis embryos. Dev Biol (1988) 2.79
Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol (2004) 2.33
Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells (1998) 2.33
Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis (1999) 2.16
Thermodynamics of beta-catenin-ligand interactions: the roles of the N- and C-terminal tails in modulating binding affinity. J Biol Chem (2005) 2.04
Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J (1997) 1.97
Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. EMBO J (2002) 1.91
Casein kinase II phosphorylation of E-cadherin increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. J Biol Chem (2000) 1.90
Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat Genet (1999) 1.90
Protein kinase CK2 in mammary gland tumorigenesis. Oncogene (2001) 1.90
Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology (Bethesda) (2007) 1.89
Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol (2003) 1.85
Analysis of the signaling activities of localization mutants of beta-catenin during axis specification in Xenopus. J Cell Biol (1997) 1.81
Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol (2005) 1.79
Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J Biol Chem (2000) 1.69
Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr Opin Cell Biol (1999) 1.63
Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis. Mol Biol Cell (2003) 1.62
Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J (2007) 1.55
Murine mammary tumor virus (MuMTV) infection of an epithelial cell line established from C57BL/6 mouse mammary glands. Virology (1978) 1.54
The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol (2007) 1.52
CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J Biol Chem (2003) 1.51
Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J Biol Chem (2000) 1.46
Casein kinase 2 Is activated and essential for Wnt/beta-catenin signaling. J Biol Chem (2006) 1.44
Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability. J Cell Sci (2002) 1.44
Protein kinase CK2--a key suppressor of apoptosis. Adv Enzyme Regul (2008) 1.39
Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc Natl Acad Sci U S A (2006) 1.39
The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. J Biol Chem (2001) 1.35
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol (2005) 1.34
Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src. J Biol Chem (1997) 1.31
CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol Cell Biochem (2005) 1.30
CK2 controls the recruitment of Wnt regulators to target genes in vivo. Curr Biol (2006) 1.30
Wnt signaling and dorso-ventral axis specification in vertebrates. Curr Opin Genet Dev (1999) 1.25
Wnt signaling stabilizes the dual-function protein beta-catenin in diverse cell types. Ann N Y Acad Sci (1998) 1.22
Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol Cell Biol (2001) 1.21
The shape of things to come: an emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal (2005) 1.19
Wnt4 inhibits beta-catenin/TCF signalling by redirecting beta-catenin to the cell membrane. Biol Cell (2008) 1.17
Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells. Int Immunol (1999) 1.17
Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep (2008) 1.12
Membrane-tethered Drosophila Armadillo cannot transduce Wingless signal on its own. Development (1999) 1.08
Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos. Dev Biol (2004) 1.08
Protein phosphatase 2Calpha dephosphorylates axin and activates LEF-1-dependent transcription. J Biol Chem (2000) 1.06
Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein. Proc Natl Acad Sci U S A (2002) 1.01
Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK. J Biol Chem (2005) 0.99
The control of beta-catenin and TCF during embryonic development and cancer. Cancer Metastasis Rev (1999) 0.99
Chimeric Wnt proteins define the amino-terminus of Wnt-1 as a transformation-specific determinant. Oncogene (1999) 0.98
Casein kinase 2, circadian clocks, and the flight from mutagenic light. Mol Cell Biochem (2005) 0.98
The disruption of adherens junctions is associated with a decrease of E-cadherin phosphorylation by protein kinase CK2. Exp Cell Res (2000) 0.96
Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J (2004) 0.96
A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Cell Mol Life Sci (2005) 0.95
Expression and regulation of protein kinase CK2 during the cell cycle. Mol Cell Biochem (1999) 0.90
A role for CK2alpha/beta in Xenopus early embryonic development. Mol Cell Biochem (2005) 0.89
In situ phosphorylation of immobilized receptors on biosensor surfaces: application to E-cadherin/beta-catenin interactions. Anal Biochem (2006) 0.87
The emerging CK2 interactome: insights into the regulation and functions of CK2. Mol Cell Biochem (2008) 0.85
Cell cycle and activation of CK2. Mol Cell Biochem (2008) 0.85
Regulatory role of CK2 during the progression of cell cycle. Mol Cell Biochem (2005) 0.84
Wingless signalling alters the levels, subcellular distribution and dynamics of Armadillo and E-cadherin in third instar larval wing imaginal discs. PLoS One (2008) 0.82
Effects of rat Axin domains on axis formation in Xenopus embryos. Dev Growth Differ (2000) 0.80
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med (2004) 4.05
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest (2006) 3.49
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood (2006) 2.97
Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol (2011) 2.82
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood (2011) 2.72
Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A (2010) 2.41
Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol (2008) 2.34
Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol (2002) 2.26
T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol (2003) 1.89
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. Blood (2007) 1.83
Direct identification of PTEN phosphorylation sites. FEBS Lett (2002) 1.80
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest (2003) 1.68
Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood (2011) 1.64
Distinct functions of Rho and Rac are required for convergent extension during Xenopus gastrulation. Dev Biol (2003) 1.59
The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol (2007) 1.52
CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J Biol Chem (2003) 1.51
Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res (2005) 1.50
Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res (2002) 1.49
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene (2002) 1.43
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res (2005) 1.41
Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol (2003) 1.36
Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene (2002) 1.34
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol (2005) 1.34
Guidance of mesoderm cell migration in the Xenopus gastrula requires PDGF signaling. Development (2004) 1.33
RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol (2005) 1.32
CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol Cell Biochem (2005) 1.30
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem (2006) 1.26
New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation. J Clin Oncol (2013) 1.23
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J (2009) 1.20
Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum (2007) 1.20
Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica (2012) 1.19
Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res (2012) 1.16
SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest (2011) 1.16
Immunoglobulin light chain amyloidosis. Expert Rev Hematol (2013) 1.15
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics (2008) 1.14
Gene targeting of CK2 catalytic subunits. Mol Cell Biochem (2008) 1.12
Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep (2008) 1.12
Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos. Dev Biol (2004) 1.08
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol (2013) 1.06
The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain. Biochemistry (2010) 1.05
Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure. Transplantation (2010) 1.04
Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res (2007) 1.02
An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Amyloid (2007) 1.00
Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial. Haematologica (2012) 1.00
Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens. Mol Vis (2009) 0.97
PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. Proc Natl Acad Sci U S A (2009) 0.97
Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils. J Biol Chem (2010) 0.97
Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy. Am J Pathol (2010) 0.97
Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int (2003) 0.94
A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms. Amyloid (2012) 0.94
Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res (2012) 0.94
Lymphadenopathy as a manifestation of amyloidosis: a case series. Amyloid (2014) 0.94
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid (2005) 0.93
Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains. Biochemistry (2007) 0.93
Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis. Blood (2010) 0.91
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol (2013) 0.91
Impaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cells. Hypertension (2010) 0.90
Localized amyloidosis of the breast: a case series. Amyloid (2011) 0.90
A role for CK2alpha/beta in Xenopus early embryonic development. Mol Cell Biochem (2005) 0.89
A solitary mediastinal mass due to localized AL amyloidosis: case report and review of the literature. Amyloid (2013) 0.89
Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Reports (2013) 0.89
Dynamic expression of a LEF-EGFP Wnt reporter in mouse development and cancer. Genesis (2010) 0.88
Two distinct phosphorylation events govern the function of muscle FHOD3. Cell Mol Life Sci (2012) 0.88
Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circ Heart Fail (2008) 0.88
Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors. Biochem J (2012) 0.88
Migrating anterior mesoderm cells and intercalating trunk mesoderm cells have distinct responses to Rho and Rac during Xenopus gastrulation. Dev Dyn (2006) 0.88
Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report. Amyloid (2012) 0.88
Self-organization of vertebrate mesoderm based on simple boundary conditions. Dev Dyn (2004) 0.88
Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid (2011) 0.88
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica (2009) 0.87
Distinct effectors of platelet-derived growth factor receptor-alpha signaling are required for cell survival during embryogenesis. Proc Natl Acad Sci U S A (2005) 0.86
Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis. Blood (2010) 0.86
CK2α is essential for embryonic morphogenesis. Mol Cell Biochem (2011) 0.85
AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid (2009) 0.85
Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica (2011) 0.85
Association of acquired von Willebrand syndrome with AL amyloidosis. Am J Hematol (2007) 0.85
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol (2002) 0.84
The mitochondrial-apoptotic pathway is triggered in Xenopus mesoderm cells deprived of PDGF receptor signaling during gastrulation. Dev Biol (2004) 0.84
Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis. Ann Hematol (2009) 0.84
Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrol Dial Transplant (2010) 0.83
Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis. Clin Lymphoma Myeloma Leuk (2010) 0.83
Macroglossia - not always AL amyloidosis. Amyloid (2011) 0.80
Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literature. Amyloid (2015) 0.79
High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease. Kidney Int (2003) 0.79
Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Mol Cell Biochem (2011) 0.78
Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt). Hum Genet (2014) 0.78
Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment. Biol Blood Marrow Transplant (2012) 0.78
Apoptosis regulates notochord development in Xenopus. Dev Biol (2007) 0.78
Risk of second primary malignancy in patients with AL amyloidosis treated with lenalidomide. Am J Hematol (2013) 0.78
Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis. J Am Heart Assoc (2013) 0.77